Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Racial/Ethnic Estimates of AD and Related Dementias

Alzheimers Dement; ePub 2018 Sep 19; Matthews, et al

Alzheimer disease and related dementias (ADRD) cause a high burden of morbidity and mortality in the US. This according to a recent study that estimated the future US burden of ADRD by age, sex, and race and ethnicity by applying subgroup-specific prevalence among Medicare Fee-for-Service beneficiaries aged ≥65 years in 2014 to subgroup-specific population estimates for 2014 and population projection data from the US Census Bureau for 2015 to 2060. Investigators found:

  • The burden of ADRD in 2014 was an estimated 5 million adults aged ≥65 years or 1.6% of the population, and there are significant disparities in ADRD prevalence among population subgroups defined by race and ethnicity.
  • ADRD burden will double to 3.3% by 2060 when 13.9 million Americans are projected to have the disease.
Citation:

Matthews KA, Xu W, Gagliotti AH, et al. Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years. [Published online ahead of print September 19, 2018]. Alzheimers Dement. doi:10.1016/j.jalz.2018.06.3063.